These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 26628252)

  • 1. A Homogeneous Immunoassay Method for Detecting Interferon-Gamma in Patients with Latent Tuberculosis Infection.
    Wu F; Wang L; Guo Q; Zhao M; Gu H; Xu H; Lou J
    J Microbiol Biotechnol; 2016 Mar; 26(3):588-95. PubMed ID: 26628252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of interferon-γ release assays (IGRAs) to the diagnosis of latent tuberculosis infection after renal transplantation.
    Hadaya K; Bridevaux PO; Roux-Lombard P; Delort A; Saudan P; Martin PY; Janssens JP
    Transplantation; 2013 Jun; 95(12):1485-90. PubMed ID: 23694948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study.
    Alsleben N; Ruhwald M; Rüssmann H; Marx FM; Wahn U; Magdorf K
    Scand J Infect Dis; 2012 Apr; 44(4):256-62. PubMed ID: 22103555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of IFN-γ and IP-10 detection in the diagnosis of latent tuberculosis infection in patients with inflammatory rheumatic diseases.
    Villar-Hernández R; Latorre I; Mínguez S; Díaz J; García-García E; Muriel-Moreno B; Lacoma A; Prat C; Olivé A; Ruhwald M; Mateo L; Domínguez J
    J Infect; 2017 Oct; 75(4):315-325. PubMed ID: 28751171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interferon-gamma assays T-SPOT.TB for the diagnosis of latent tuberculosis infection].
    Borkowska D; Zwolska Z; Michałowska-Mitczuk D; Korzeniewska-Koseła M; Zabost A; Napiórkowska A; Kozińska M; Brzezińska S; Augustynowicz-Kopeć E
    Pneumonol Alergol Pol; 2011; 79(4):264-71. PubMed ID: 21678276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the T-cell-based interferon-gamma releasing assay feasible for diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country?
    Dilektasli AG; Erdem E; Durukan E; Eyüboğlu FÖ
    Jpn J Infect Dis; 2010 Nov; 63(6):433-6. PubMed ID: 21099095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of latent tuberculosis infection in bacille Calmette-Guérin vaccinated subjects in China by interferon-gamma ELISpot assay.
    Zhang M; Wang H; Liao M; Chen X; Graner M; Zhu X; Zhang J; Yang Q; Lu H; Zhou B; Chen X
    Int J Tuberc Lung Dis; 2010 Dec; 14(12):1556-63. PubMed ID: 21144240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
    Sato S; Nagai H
    Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a one-step probe based molecular assay for rapid immunodiagnosis of infection with M. tuberculosis using dried blood spots.
    Blauenfeldt T; Heyckendorf J; Graff Jensen S; Lange C; Drabe C; Hermansen TS; de Thurah L; Lillebaek T; Eugen-Olsen J; Seersholm N; Hoff S; Bonde J; Ruhwald M
    PLoS One; 2014; 9(9):e105628. PubMed ID: 25184553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosing latent tuberculosis infection in haemodialysis patients: T-cell based assay (T-SPOT.TB) or tuberculin skin test?
    Soysal A; Toprak D; Koc M; Arikan H; Akoglu E; Bakir M
    Nephrol Dial Transplant; 2012 Apr; 27(4):1645-50. PubMed ID: 21931124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon gamma mRNA quantitative real-time polymerase chain reaction for the diagnosis of latent tuberculosis: a novel interferon gamma release assay.
    Kim S; Kim YK; Lee H; Cho JE; Kim HY; Uh Y; Kim YM; Kim H; Cho SN; Jeon BY; Lee H
    Diagn Microbiol Infect Dis; 2013 Jan; 75(1):68-72. PubMed ID: 23102550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of tuberculin skin testing and T-SPOT.TB for diagnosis of latent and active tuberculosis.
    Simsek H; Alpar S; Ucar N; Aksu F; Ceyhan I; Gözalan A; Cesur S; Ertek M
    Jpn J Infect Dis; 2010 Mar; 63(2):99-102. PubMed ID: 20332570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Latent Tuberculosis Infection Screening and 2-Year Outcome in Antiretroviral-Naive HIV-Infected Patients in a Low-Prevalence Country.
    Bourgarit A; Baron G; Breton G; Tattevin P; Katlama C; Allavena C; Campa P; Ravaud P; Lortholary O; Carcelain G;
    Ann Am Thorac Soc; 2015 Aug; 12(8):1138-45. PubMed ID: 26213798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-γ/TNF-α ratio in response to immuno proteomically identified human T-cell antigens of Mycobacterium tuberculosis - The most suitable surrogate biomarker for latent TB infection.
    Prabhavathi M; Pathakumari B; Raja A
    J Infect; 2015 Aug; 71(2):238-49. PubMed ID: 25936741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients.
    Triverio PA; Bridevaux PO; Roux-Lombard P; Niksic L; Rochat T; Martin PY; Saudan P; Janssens JP
    Nephrol Dial Transplant; 2009 Jun; 24(6):1952-6. PubMed ID: 19164327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-gamma release assays for the diagnosis of latent tuberculosis infection: an updated review.
    Moon HW; Hur M
    Ann Clin Lab Sci; 2013; 43(2):221-9. PubMed ID: 23694799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity of the tuberculin skin test and the T-SPOT.TB assay among students in a low-tuberculosis incidence setting.
    Talbot EA; Harland D; Wieland-Alter W; Burrer S; Adams LV
    J Am Coll Health; 2012; 60(1):94-6. PubMed ID: 22171735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of rituximab therapy on released interferon-γ levels in the QuantiFERON assay among RA patients with different status of Mycobacterium tuberculosis infection.
    Chen YM; Chen HH; Lai KL; Hung WT; Lan JL; Chen DY
    Rheumatology (Oxford); 2013 Apr; 52(4):697-704. PubMed ID: 23264552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermostability of IFN-γ and IP-10 release assays for latent infection with Mycobacterium tuberculosis: A TBnet study.
    Blauenfeldt T; Wagner D; Aabye M; Heyckendorf J; Lange B; Lange C; Ernst M; Ravn P; Duarte R; Morais C; Hoffmann M; Schoch OD; Dominguez J; Latorre I; Ruhwald M
    Tuberculosis (Edinb); 2016 May; 98():7-12. PubMed ID: 27156612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.